Synergistic recruitment of UbcH7~Ub and phosphorylated Ubl domain triggers parkin activation

Condos, T. E.C., Dunkerley, K. M., Freeman, E. A., Barber, K. R., Aguirre, J. D., Chaugule, V. K., Xiao, Y., Konermann, L., Walden, H. and Shaw, G. S. (2018) Synergistic recruitment of UbcH7~Ub and phosphorylated Ubl domain triggers parkin activation. EMBO Journal, e100014. (doi: 10.15252/embj.2018100014) (PMID:30446597)

[img]
Preview
Text
174181.pdf - Published Version
Available under License Creative Commons Attribution.

2MB

Abstract

The E3 ligase parkin ubiquitinates outer mitochondrial membrane proteins during oxidative stress and is linked to early-onset Parkinson’s disease. Parkin is autoinhibited but is activated by the kinase PINK1 that phosphorylates ubiquitin leading to parkin recruitment, and stimulates phosphorylation of parkin’s N-terminal ubiquitin-like (pUbl) domain. How these events alter the structure of parkin to allow recruitment of an E2~Ub conjugate and enhanced ubiquitination is an unresolved question. We present a model of an E2~Ub conjugate bound to the phosphoubiquitin-loaded C-terminus of parkin, derived from NMR chemical shift perturbation experiments. We show the UbcH7~Ub conjugate binds in the open state whereby conjugated ubiquitin binds to the RING1/IBR interface. Further, NMR and mass spectrometry experiments indicate the RING0/RING2 interface is re-modelled, remote from the E2 binding site, and this alters the reactivity of the RING2(Rcat) catalytic cysteine, needed for ubiquitin transfer. Our experiments provide evidence that parkin phosphorylation and E2~Ub recruitment act synergistically to enhance a weak interaction of the pUbl domain with the RING0 domain and rearrange the location of the RING2(Rcat) domain to drive parkin activity.

Item Type:Articles
Additional Information:This work was supported by postgraduate scholarships from the Natural Sciences and Engineering Research Council of Canada (TECC, KMD), a collaborative travel grant from Boehringer-Ingelheim Fonds (TECC), research grants from the Canadian Institutes of Health Research (MOP-14606) to GSS, Medical Research Council (MC_UU_12016/12) to HW and Natural Sciences and Engineering Research Council of Canada (RGPIN-2018-04243) to LK, and a Wellcome Trust Investigator Award (209347/Z/17/Z) to HW.
Status:Published
Refereed:Yes
Glasgow Author(s) Enlighten ID:Chaugule, Dr Viduth and Walden, Professor Helen
Authors: Condos, T. E.C., Dunkerley, K. M., Freeman, E. A., Barber, K. R., Aguirre, J. D., Chaugule, V. K., Xiao, Y., Konermann, L., Walden, H., and Shaw, G. S.
College/School:College of Medical Veterinary and Life Sciences > School of Molecular Biosciences
Journal Name:EMBO Journal
Publisher:EMBO Press
ISSN:0261-4189
ISSN (Online):1460-2075
Copyright Holders:Copyright © 2018 The Authors
First Published:First published in EMBO Journal e100014
Publisher Policy:Reproduced under a Creative Commons License

University Staff: Request a correction | Enlighten Editors: Update this record

Project CodeAward NoProject NamePrincipal InvestigatorFunder's NameFunder RefLead Dept
3011020Mechanisms of ubiquitin signalling in Parkinson's DiseaseHelen WaldenWellcome Trust (WELLCOTR)209347/Z/17/ZInstitute of Molecular, Cell & Systems Biology